The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intramuscular Drug Delivery Market Research Report 2024
Synopsis
The global Intramuscular Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intramuscular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Drug Delivery.
Report Scope
The Intramuscular Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intramuscular Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intramuscular Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Antares Pharma
Eli Lily
Galaxo
HMD pharmaceuticals
Inovio Pharmaceuticals
Merck
Novartis
Pacira Pharmaceuticals
Pfizer
Pharmajet
Teva Pharmaceutical
Segment by Type
Drug Molecule
Delivery Devices
Segment by Application
Infectious Disease
Oncology
Autoimmune Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intramuscular Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Intramuscular Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intramuscular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Drug Delivery.
Report Scope
The Intramuscular Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intramuscular Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intramuscular Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Antares Pharma
Eli Lily
Galaxo
HMD pharmaceuticals
Inovio Pharmaceuticals
Merck
Novartis
Pacira Pharmaceuticals
Pfizer
Pharmajet
Teva Pharmaceutical
Segment by Type
Drug Molecule
Delivery Devices
Segment by Application
Infectious Disease
Oncology
Autoimmune Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intramuscular Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Molecule
1.2.3 Delivery Devices
1.3 Market by Application
1.3.1 Global Intramuscular Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Autoimmune Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intramuscular Drug Delivery Market Perspective (2019-2030)
2.2 Intramuscular Drug Delivery Growth Trends by Region
2.2.1 Global Intramuscular Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Intramuscular Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Intramuscular Drug Delivery Market Dynamics
2.3.1 Intramuscular Drug Delivery Industry Trends
2.3.2 Intramuscular Drug Delivery Market Drivers
2.3.3 Intramuscular Drug Delivery Market Challenges
2.3.4 Intramuscular Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intramuscular Drug Delivery Players by Revenue
3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intramuscular Drug Delivery Revenue
3.4 Global Intramuscular Drug Delivery Market Concentration Ratio
3.4.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2023
3.5 Intramuscular Drug Delivery Key Players Head office and Area Served
3.6 Key Players Intramuscular Drug Delivery Product Solution and Service
3.7 Date of Enter into Intramuscular Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intramuscular Drug Delivery Breakdown Data by Type
4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Intramuscular Drug Delivery Breakdown Data by Application
5.1 Global Intramuscular Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Intramuscular Drug Delivery Market Size (2019-2030)
6.2 North America Intramuscular Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Intramuscular Drug Delivery Market Size by Country (2019-2024)
6.4 North America Intramuscular Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intramuscular Drug Delivery Market Size (2019-2030)
7.2 Europe Intramuscular Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Intramuscular Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Intramuscular Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intramuscular Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Intramuscular Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intramuscular Drug Delivery Market Size (2019-2030)
9.2 Latin America Intramuscular Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Intramuscular Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Intramuscular Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intramuscular Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Intramuscular Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Antares Pharma
11.1.1 Antares Pharma Company Detail
11.1.2 Antares Pharma Business Overview
11.1.3 Antares Pharma Intramuscular Drug Delivery Introduction
11.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.1.5 Antares Pharma Recent Development
11.2 Eli Lily
11.2.1 Eli Lily Company Detail
11.2.2 Eli Lily Business Overview
11.2.3 Eli Lily Intramuscular Drug Delivery Introduction
11.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.2.5 Eli Lily Recent Development
11.3 Galaxo
11.3.1 Galaxo Company Detail
11.3.2 Galaxo Business Overview
11.3.3 Galaxo Intramuscular Drug Delivery Introduction
11.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.3.5 Galaxo Recent Development
11.4 HMD pharmaceuticals
11.4.1 HMD pharmaceuticals Company Detail
11.4.2 HMD pharmaceuticals Business Overview
11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction
11.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.4.5 HMD pharmaceuticals Recent Development
11.5 Inovio Pharmaceuticals
11.5.1 Inovio Pharmaceuticals Company Detail
11.5.2 Inovio Pharmaceuticals Business Overview
11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction
11.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.5.5 Inovio Pharmaceuticals Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Intramuscular Drug Delivery Introduction
11.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Intramuscular Drug Delivery Introduction
11.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 Pacira Pharmaceuticals
11.8.1 Pacira Pharmaceuticals Company Detail
11.8.2 Pacira Pharmaceuticals Business Overview
11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction
11.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.8.5 Pacira Pharmaceuticals Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Intramuscular Drug Delivery Introduction
11.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Pharmajet
11.10.1 Pharmajet Company Detail
11.10.2 Pharmajet Business Overview
11.10.3 Pharmajet Intramuscular Drug Delivery Introduction
11.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.10.5 Pharmajet Recent Development
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Detail
11.11.2 Teva Pharmaceutical Business Overview
11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction
11.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2019-2024)
11.11.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
